We have demonstrated that BK channel blocker played an important role in the inhibition of HCC growth and metastasis in vivo, suggesting that these channels may represent a promising candidate therapeutic target for HCC. This evidence concerns the gene KCNMA1 and hepatocellular carcinoma.